Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.
Xiang Y, Xu J, McGovern BL, Ranzenigo A, Huang W, Sang Z, Shen J, Diaz-Tapia R, Pham ND, Teunissen AJP, Rodriguez ML, Benjamin J, Taylor DJ, van Leent MMT, White KM, García-Sastre A, Zhang P, Shi Y.
Xiang Y, et al. Among authors: white km.
Cell. 2024 Nov 27;187(24):6966-6980.e23. doi: 10.1016/j.cell.2024.09.043. Epub 2024 Oct 23.
Cell. 2024.
PMID: 39447570